Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Study of Oral ASN51 in Healthy Subjects and Subjects With Alzheimer's Disease
- First Posted Date
- 2021-02-18
- Last Posted Date
- 2023-01-17
- Lead Sponsor
- Asceneuron Pty Ltd.
- Target Recruit Count
- 25
- Registration Number
- NCT04759365
- Locations
- 🇦🇺
Nucleus Network, Melbourne, Victoria, Australia
© Copyright 2025. All Rights Reserved by MedPath